Product Information: Hoffmann — La Roche, Nutley, New Jersey.
2.
KaplanS. A.: Pharmacokinetic Profiles of Clonazepam in Dog and Humans and of Flunitiazepam in Dog, J. Pharm. Sci.63: 527 (Apr.) 1974.
3.
de SilvaJ. A. F.: Determination of Clonazepam and Flunitiazepam in Blood and Urine by Electron Capture GCL, J. Pharm. Sci.63: 520 (Apr.) 1974.
4.
Guerroro-FigueroaR.: Effects of Two Benzodiazepine Derivatives on Cortical and Subcortical Epileptogenic Tissues in the Cat and Monkey, I. Limbic System Structures, II. Cortical and Centren-Cephalic Structures. Curr. Ther. Res.11: 27 (Jan.) 1969.
5.
BlumJ. E.: Pharmakologic und Toxikologie des Antiepileptikums Clonazepam, Arznetm-Forsch.23: 377 (Mar.) 1973.
6.
Guerrero-FigueroaR.: Electrophysiological Analysis of the Action of Four Benzodiazepine Derivatives on the Central Nervous System, In Proc. Int. Symposium Benzodiazepines, Milan, Italy, 1971, p. 32.
7.
Data on File: Medical Department, Hoffmann-La Roche, Nutley, New Jersey.
8.
HooshmandH.: Intractable Seizures, Treatment with a New Benzodiazepine Anticonvulsant, Arch. Neurol.27: 205 (Sept.) 1972.
9.
BarnettA. M.: Treatment of Epilepsy with Clonazepam (R05-4023), S. A. Med. J.47: 1683 (Sept.) 1973.
10.
GastantH.: Exceptional Anti-epileptic Properties of a New Benzodiazepine, Vie Med.51: 5175–5176, 5183–5188, 1970.
11.
DreifussF. E.: Serum Clonazepam Concentrations in Children with Absence Seizures, Neurol.25: 255 (Mar.) 1975.
12.
NaestoftJ.: Assay and Pharmacokinetics of Clonazepam in Humans, Acta. Neurol. Scand.49, Suppl. 53: 103, 1973.
13.
SjoO.: Pharmacokinetics and Side-Effects of Clonazepam and Its 7-Amino Metabolite in Man, Europ. J. Clin. Pharmacol.8: 249 (Apr.) 1975.
14.
HansonR. A.: A New Anticonvulsant in the Management of Minor Motor Seizures, Dev. Med. Child. Neurol.14: 3–14 (Feb.) 1972.
15.
DumermuthG.: The Effect of Clonazepam (R05-4023) in the Syndrome of Infantile Spasms of Hypsarrhythmia and in Petit Mal Variant or Lennox Syndrome, Acta. Neurol. Scand.49, Suppl. 53: 26–28, 1973.
16.
BladinP. F.: The Use of Clonazepam as an Anticonvulsant, Med. J. Aust.1: 683 (Apr.) 1973.
17.
AarliJ. A.: Effect of Clonazepam (R05-4023) on Epileptic Seizures, Acta. Neurol. Scand.49, Suppl. 53: 11–17, 1973.
18.
FazioC.: Treatment of Epileptic Seizures with Clonazepam, Arch. Neurol.32: 304–307 (May) 1975.
19.
GastantH.: Treatment of Status Epilepticus with a New Benzodiazepine More Active Than Diazepam, Epilepsia12: 197 (Mar.) 1971.
20.
MartinD.: Clinical Experience with Clonazepam (Rivotril) in the Treatment of Epilepsies in Infancy and Childhood, Neuropadiatrie4: 245 (July) 1973.
21.
HollisterL.: Dose-Ranging Studies of Clonazepam in Man, Psychopharmacol. Commun.1: 89, 1975.
22.
LehtovaaraR.: A Clinical Trial with Clonazepam (R05-4023), Acta. Neurol. Scand.49: Suppl 53: 77–81, 1973.
23.
Munth-KaasA. W.: Clonazepam in the Traetment of Epileptic Seizures, Acta. Neurol. Scand.49: Suppl. 53: 97, 1973.
24.
MikkelsonB.: A Clinical Study of the Benzodiazepine R05-4023 (Clonazepam) in the Treatment of Epilepsy, Acta. Neurol. Scand.49: Suppl. 53: 91, 1973.
25.
LundM.: Clonazepam in the Treatment of Epilepsy, Acta. Neurol. Scand.49: Suppl. 53: 82–90, 1973.
26.
ElianM.: The Rate of Dosage Increase of Clonazepam, Acta Neurol. Scand.49: Suppl. 53: 32, 1973.
27.
Birket-SmithE.: A Controlled Trial on R05-4023 (Clonazepam) In the Treatment of Psychomotor Epilepsy, Acta. Neurol. Scand.49: Suppl. 53: 18–25, 1973.